Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of iRhythm Technologies Inc (NASDAQ: IRTC) violated securities laws in connection with certain financial statements.
The investigation seeks to discover if possible claims on behalf of purchasers of the securities of iRhythm Technologies Inc (NASDAQ: IRTC) concerning whether a series of statements by iRhythm Technologies Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On March 13, 2019, a report released by Kerrisdale Capital claimed that “at the core of iRhythm’s revenue base is an exceedingly generous, but increasingly fragile, reimbursement regime.”
On March 27, 2019, a report released by Washington Analysis LLC estimated that the company could face a 45%-65% reimbursement cut for its Zio XT Patch.
Following this news, NASDAQ: IRTC fell $14.02 per share, or over 16%, over several trading sessions to close at $73.24 on March 28, 2019.
Based in San Francisco, California, and founded in 2006 iRhythm Technologies Inc provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States.
If you purchased shares of iRhythm Technologies Inc (NASDAQ: IRTC) on or before March 13, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.
Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.
Thieler Law Corp
2534 State Street - Suite 406,
San Diego, CA 92101
by
email: mail@thielerlaw.com
or
telephone at +1 (619) 377 - 4324
or
visit our website http://www.thielerlaw.com/
or
Facsimile: +1 (619) 785 – 3185